VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
London Stock Exchange Group plc vs Merck & Co., Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
London Stock Exchange Group plc
LSEG · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into London Stock Exchange Group plc's moat claims, evidence, and risks.
View LSEG analysisMerck & Co., Inc.
MRK · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Merck & Co., Inc.'s moat claims, evidence, and risks.
View MRK analysisComparison highlights
- Moat score gap: London Stock Exchange Group plc leads (74 / 100 vs 71 / 100 for Merck & Co., Inc.).
- Segment focus: London Stock Exchange Group plc has 5 segments (51% in Data & Analytics); Merck & Co., Inc. has 2 segments (89.5% in Pharmaceutical).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: London Stock Exchange Group plc has 8 moat types across 4 domains; Merck & Co., Inc. has 5 across 3.
Primary market context
London Stock Exchange Group plc
Data & Analytics
Financial market data, analytics and workflows (terminals and enterprise feeds)
Global
Financial institutions and corporates
Data & analytics vendor
51%
Merck & Co., Inc.
Pharmaceutical
Branded prescription pharmaceuticals & human vaccines
Global
Wholesalers/retailers, managed care and government payers, hospitals/clinics
R&D-intensive innovator, manufacturer, and marketer
89.5%
Side-by-side metrics
Moat coverage
Shared moat types
London Stock Exchange Group plc strengths
Merck & Co., Inc. strengths
Segment mix
London Stock Exchange Group plc segments
Full profile >Data & Analytics
Oligopoly
FTSE Russell
Oligopoly
Risk Intelligence
Oligopoly
Capital Markets
Oligopoly
Post Trade
Quasi-Monopoly
Merck & Co., Inc. segments
Full profile >Pharmaceutical
Competitive
Animal Health
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.